title: Characterization of a subpopulation of colon cancer cells with stem cell-like properties.
abstract: The biology of the normal colonic mucosa suggests that colon cancer originates from normal colon stem cells. CD44 cancer stem cells have been identified in breast and prostate cancer, and we therefore examined whether CD44 similarly identified colon cancer stem cells. Initial assays found CD44(hi) colon tumor cells to have enhanced soft agar colony-forming ability. Subsequently, CD44(hi) cells isolated from 4 primary colon adenocarcinoma xenografts were found to be highly tumorigenic in immune deficient mice. CD44(hi) cells consistently formed tumors with 1,000 cells, and in multiple experiments, as few as 10 and 100 CD44(hi) cells formed tumors in 7/10 and 21/28 mice, respectively. In contrast, CD44(-) colon tumor cells were either nontumorigenic or 10-50-fold less tumorigenic. CD44(hi) cells could be serially passaged up to 4 times in vivo, suggesting self-renewal capacity, and formed tumors that recapitulated the heterogeneity of the original patient tumor. CD44(hi) cells were significantly enriched for nuclear activated beta-catenin, a key element in normal stem/progenitor cells and in early colon tumor progression. Bromodeoxyuridine (BrdU) labeling studies indicated that CD44(hi) cells divide slowly relative to the CD44(-) cells, suggesting their tumorigenicity is not simply due to faster proliferation. Aldehyde dehydrogenase (ALDH) sort further increased the tumorigenicity of CD44(hi) cells from 2/2 patient tumors, but CD133 tumor cells in our hands did not have increased tumorigenicity. Our observations indicate that CD44 is a marker of stem-like cells in colon cancer, and support the use of additional markers to further purify colon cancer stem cells.
authors.affiliation: Department of Discovery Oncobiology, Biogen Idec, San Diego, CA 92122, USA. peter.chu@biogenidec.com
authors.forename: Peter
authors.initials: P
authors.lastname: Chu
authors.forename: Dana J
authors.initials: DJ
authors.lastname: Clanton
authors.forename: Tracey S
authors.initials: TS
authors.lastname: Snipas
authors.forename: Julia
authors.initials: J
authors.lastname: Lee
authors.forename: Eric
authors.initials: E
authors.lastname: Mitchell
authors.forename: Mai-Lan
authors.initials: ML
authors.lastname: Nguyen
authors.forename: Eric
authors.initials: E
authors.lastname: Hare
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Peach
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000473:pathology*; D019049:Developed Countries; D005434:Flow Cytometry; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D015994:Incidence; D007413:Intestinal Mucosa / Q000473:pathology*; D051379:Mice; D016513:Mice, SCID; D008822:Mice, Transgenic; D013234:Stem Cells / Q000166:cytology / Q000473:pathology*; D014183:Transplantation, Heterologous
chemical_list: D015703:Antigens, CD; D018960:Hyaluronan Receptors